International Oncology Network - Cancer & Hematology News
All Blog Posts Tagged 'X-PECT' (1)
X-PECT Study of Perifosine (KRX-0401) for the Treatment of Refractory Advanced Colorectal Cancer to Proceed
An independent Data Safety Monitoring Board (DSMB) for Keryx Biopharmaceuticals' pivotal Phase III X-PECT study of Perifosine (KRX-0401) in patients with refractory advanced colorectal cancer has completed a pre-specified interim analysis for safety and futility. The independent board has recommended that the Phase III study continue to completion, as planned.
Perifosine (KRX-0401) is a novel, potentially… Continue
Perifosine (KRX-0401) is a novel, potentially… Continue
Added by Peter Hofland, PhD on August 31, 2011 at 6:00am — No Comments
Latest Blog Posts
Most Popular Blog Posts
Monthly Archives
2013
2012
- December (32)
- November (19)
- October (17)
- September (9)
- August (10)
- July (4)
- June (29)
- May (16)
- April (6)
- March (4)
- February (21)
- January (38)
2011
- December (47)
- November (32)
- October (21)
- September (32)
- August (18)
- July (23)
- June (83)
- May (45)
- April (54)
- March (36)
- February (62)
- January (43)
2010
- December (58)
- November (49)
- October (65)
- September (23)
- August (7)
- July (4)
- June (34)
- May (7)
- April (7)
- March (5)
- February (3)
- January (6)
2009
2008
- December (19)
2007
- April (1)
2005
2004
- September (1)
2001
- November (1)
ADVERTISEMENT
Bookmark / Share
Join the Conversation!
© 2013 Created by Peter Hofland, PhD.
